|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-3-9
|
|
pubmed:abstractText |
To ascertain the loco-regional recurrence (LRR) rate and its major prognostic factors in patients younger than 40 and to determine the influence of age on the features of breast cancer and its treatment in two age groups: 35 years and [36-39] years.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0167-8140
|
|
pubmed:author |
pubmed-author:BolletMarc AMA,
pubmed-author:CampanaFrançoisF,
pubmed-author:DendaleRémiR,
pubmed-author:FourquetAlainA,
pubmed-author:KirovaYoulia MYM,
pubmed-author:MazeauValérieV,
pubmed-author:SalmonRémyR,
pubmed-author:SavignoniAlexiaA,
pubmed-author:Sigal-ZafraniBrigitteB,
pubmed-author:Vincent-SalomonAnneA,
pubmed-author:de la RochefordièreAnneA
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
82
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
272-80
|
|
pubmed:dateRevised |
2008-6-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17287037-Adult,
pubmed-meshheading:17287037-Age Factors,
pubmed-meshheading:17287037-Breast Neoplasms,
pubmed-meshheading:17287037-Carcinoma, Ductal, Breast,
pubmed-meshheading:17287037-Carcinoma, Lobular,
pubmed-meshheading:17287037-Combined Modality Therapy,
pubmed-meshheading:17287037-Disease-Free Survival,
pubmed-meshheading:17287037-Female,
pubmed-meshheading:17287037-Follow-Up Studies,
pubmed-meshheading:17287037-Humans,
pubmed-meshheading:17287037-Lymph Node Excision,
pubmed-meshheading:17287037-Mastectomy, Segmental,
pubmed-meshheading:17287037-Neoplasm Recurrence, Local,
pubmed-meshheading:17287037-Prognosis,
pubmed-meshheading:17287037-Survival Rate
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first.
|
|
pubmed:affiliation |
Department of Radiation Oncology, Institut Curie, Paris, France. marc.bollet@curie.net
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
